TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 74 filers reported holding TRINITY BIOTECH PLC in Q4 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $761,000 | +15.5% | 57,601 | -0.9% | 0.19% | +9.2% |
Q2 2016 | $659,000 | +3.3% | 58,101 | +6.2% | 0.17% | +9.4% |
Q1 2016 | $638,000 | +2.7% | 54,701 | +3.6% | 0.16% | +17.8% |
Q4 2015 | $621,000 | -80.0% | 52,801 | -80.6% | 0.14% | -79.3% |
Q3 2015 | $3,110,000 | -32.6% | 271,860 | +6.4% | 0.65% | -20.8% |
Q2 2015 | $4,615,000 | -6.3% | 255,559 | -0.1% | 0.82% | -5.3% |
Q1 2015 | $4,923,000 | +9.9% | 255,759 | -0.0% | 0.87% | +6.1% |
Q4 2014 | $4,480,000 | +590.3% | 255,859 | +620.7% | 0.82% | +576.9% |
Q3 2014 | $649,000 | -21.7% | 35,500 | -1.4% | 0.12% | -13.6% |
Q2 2014 | $829,000 | -15.8% | 36,000 | -11.3% | 0.14% | -10.8% |
Q1 2014 | $984,000 | -21.7% | 40,600 | -18.8% | 0.16% | -24.5% |
Q4 2013 | $1,257,000 | +15.5% | 50,000 | 0.0% | 0.21% | -1.9% |
Q3 2013 | $1,088,000 | +29.2% | 50,000 | 0.0% | 0.21% | +12.2% |
Q2 2013 | $842,000 | – | 50,000 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
Centaur Capital | 135,000 | $2,599,000 | 3.61% |
GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
RK Capital | 601,672 | $11,582,000 | 2.31% |
Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |